Pictor® Holdings Inc. Secures $7.5 Million Bridge Round to Accelerate Commercialization of Targeted Proteomic Platform
Investment brings Pictor's total capital raised to approximately $30 million, supporting expanded U.S. and international commercialization effortsCARLSBAD, Calif., June 30, 2026...
Hemostemix to Highlight Commercial Phase I Longevity Treatment at Small Cap Growth Investor Conference